论文部分内容阅读
目的研讨小儿咳嗽运用小儿肺热咳喘颗粒治疗的临床价值。方法从我院2010年12月-2015年12月选取500例小儿咳嗽病例做随机非盲法分组试验与研究,每组250例,Ⅰ组接受常规对症治疗,Ⅱ组在上述治疗下接受小儿肺热咳喘颗粒用药,1个疗程后,从药效、咳嗽缓解时间及安全性等方面评估该两种方案的临床应用情况。结果Ⅱ组患儿接受治疗后,取得了95.2%的总有效率,相比Ⅰ组的82.0%显著提高,数据满足P<0.05,统计学成立。Ⅱ组的咳嗽缓解时间为(4.83±1.14)d,相比Ⅰ组的(6.78±1.35)d显著缩短,数据满足P<0.05,统计学成立。两组在试验期间均未产生明显副作用。结论对咳嗽患儿运用小儿肺热咳喘颗粒治疗,药效温和、可靠,可有效促进咳嗽症状的缓解,值得加强推广。
Objective To study the clinical value of children’s Hyperactivity and Relieving Kechuan Granule in treating pediatric cough. Methods From December 2010 to December 2015 in our hospital, 500 cases of pediatric cough were selected and randomly divided into two groups. 250 cases in each group were treated with conventional symptomatic treatment. Group Ⅱ received pediatric lung Heat cough granules medication, after a course of treatment, from the efficacy, cough relief time and safety assessment of the two programs of clinical application. Results After treatment, the total effective rate of 95.2% in group Ⅱ was significantly higher than that in group Ⅰ (82.0%). The data met the criteria of P <0.05 and the statistics was established. The time to relieve cough in group Ⅱ was (4.83 ± 1.14) d, which was significantly shorter than that in group Ⅰ (6.78 ± 1.35) d. The data met the criteria of P <0.05 and the statistics was established. Both groups had no significant side effects during the trial. Conclusion The treatment of children with Hyperactivity Kechuan granules in children with cough has moderate and reliable efficacy and can effectively alleviate the symptoms of cough and is worth promoting.